ASF Research Funding Program
The ASF Research Funding Program by the Alport Syndrome Foundation funds innovative basic and clinical research to advance understanding and treatment of Alport syndrome.
Funder: Alport Syndrome Foundation
Due Dates (Anticipated): March 2027 (projected)
Funding Amounts: Typical awards $100,000–$132,000 for 1–2 years; recent projects have ranged from $26,000 to $132,000; multi-year projects possible.
Summary: Supports innovative basic and clinical research to advance understanding, treatment, and potential cures for Alport syndrome.
Key Information: Covers direct research costs only (no indirect costs); invitation-only application process.
Description
The Alport Syndrome Foundation (ASF) Research Funding Program provides seed funding for both basic science and clinical research projects focused on Alport syndrome. The program aims to accelerate progress in understanding disease mechanisms, developing new treatments, and working toward a cure to prevent kidney failure and hearing loss in patients. Funding is often used to support early-stage, high-risk projects that generate preliminary data to help researchers secure larger grants from major institutions such as the NIH. ASF also invests in research tools, patient registries, and collaborative studies to benefit the broader Alport community.
